Robert J. Gyurik
No más puestos en curso
Perfil
Robert J.
Gyurik has been a Director of Bentley Pharmaceuticals, Inc. since 1998 and became Vice President of Pharmaceutical Development in March 1999.
Prior to joining Bentley, he was Manager of Development and Quality Control at MacroChem Corporation from May 1993 to February 1999.
From 1971 to 1993, he worked in various research and development positions at SmithKline Beecham.
Prior thereto, he worked at Schering as a Medicinal Chemist.
Mr. Gyurik holds a BA in Biology and Chemistry.
Antiguos cargos conocidos de Robert J. Gyurik.
| Empresas | Cargo | Fin |
|---|---|---|
Teva Spanish Holdco, Inc.
 Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Director/Miembro de la Junta | 22/07/2008 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Teva Spanish Holdco, Inc.
Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | Health Technology |
- Bolsa de valores
- Insiders
- Robert J. Gyurik
